CVRx (CVRX) Cash from Operations (2020 - 2026)
CVRx (CVRX) posted Cash from Operations of -$8.8 million for Q2 2026, up 27.44% on a QoQ basis from -$12.2 million in Q1 2026, and down 11.21% year-over-year from -$9.9 million in Q2 2025.
Analysis
CVRx (CVRX) Cash from Operations (2020 - 2026) Analysis & Trends
CVRx has reported Cash from Operations for 7 years, with the latest figure at -$8.8 million in Q2 2026.
- On a quarterly basis, Cash from Operations fell 11.21% year-over-year to -$8.8 million in Q2 2026; TTM through Jun 2026 was -$40.5 million, a 3.42% decrease from a year earlier, with the FY2025 full-year figure at -$40.2 million, down 2.62% from the prior year.
- Cash from Operations was -$8.8 million for Q2 2026 at CVRx, up from -$12.2 million in the prior quarter.
- The five-year high for Cash from Operations was -$7.8 million in Q4 2023, with the low at -$12.8 million in Q2 2023.
- Average Cash from Operations over 5 years is -$10.1 million, with a median of -$10.2 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations slumped 111.27% in 2022, then advanced 27.69% in 2023.
- Over 5 years, Cash from Operations stood at -$10.8 million in 2022, then advanced by 27.69% to -$7.8 million in 2023, then declined by 2.16% to -$8.0 million in 2024, then slipped by 21.85% to -$9.8 million in 2025, then increased by 9.55% to -$8.8 million in 2026.
- The last three Cash from Operations figures came in at -$8.8 million (Q2 2026), -$12.2 million (Q1 2026), and -$9.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 367.10 Mn |
| 10 | CVRx | 75.57 Mn | 10.98 Mn | 13.72 Mn | -8.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.83 Mn |
| Mar 31, 2026 | -12.16 Mn |
| Dec 31, 2025 | -9.76 Mn |
| Sep 30, 2025 | -9.71 Mn |
| Jun 30, 2025 | -7.94 Mn |
| Mar 31, 2025 | -12.77 Mn |
| Dec 31, 2024 | -8.01 Mn |
| Sep 30, 2024 | -10.41 Mn |
| Jun 30, 2024 | -9.83 Mn |
| Mar 31, 2024 | -10.90 Mn |
| Dec 31, 2023 | -7.84 Mn |
| Sep 30, 2023 | -8.13 Mn |
| Jun 30, 2023 | -12.81 Mn |
| Mar 31, 2023 | -10.25 Mn |
| Dec 31, 2022 | -10.84 Mn |
| Sep 30, 2022 | -11.10 Mn |
| Jun 30, 2022 | -10.10 Mn |
| Mar 31, 2022 | -10.64 Mn |
| Dec 31, 2021 | -7.02 Mn |
| Sep 30, 2021 | -9.22 Mn |